Cite
MLA Citation
Bertrand Knebelmann et al.. “FP179BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME.” Nephrology dialysis transplantation, vol. 34, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100092358215.0x000021